OPC Pharmaceutical

OPC

VN000000OPC9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 18:00:00 2024-06-10 EDT			5-day change	1st Jan Change
24,450 ^VND	-0.20%		+2.09%	+1.88%

05-13	Opc Pharmaceutical Joint Stock Company Appoints Nong Thi Lan as Member of the Internal Audit Committee	CI
05-06	OPC Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2023, Payable on May 21, 2024	CI

OPC Pharmaceutical Joint Stock Company Announces Personnel Changes

July 14, 2021 at 11:56 pm

OPC Pharmaceutical Joint Stock Company announced personnel change as follows: Mrs. Pham Thi Xuan Huong was appointed as CEO in the term V (2021 – 2026) as from July 14, 2021. OPC Pharmaceutical Joint Stock Company received the resignation letter from Mr. Truong Duc Vong as CEO as July 14, 2021.

Latest news about OPC Pharmaceutical

Opc Pharmaceutical Joint Stock Company Appoints Nong Thi Lan as Member of the Internal Audit Committee	05-13	CI
OPC Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2023, Payable on May 21, 2024	05-06	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	05-01	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	01-29	CI
OPC Pharmaceutical Joint Stock Company Receives the Resignation from Duong Minh Hung as Sales and Marketing Deputy Chief Executive Officer	12-04	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-29	CI
OPC Pharmaceutical Joint Stock Company Appoints Mrs. Nguyen Thi Hong the Person in Charge of Corporate Governance Cum Secretary	23-08-29	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-30	CI
OPC Pharmaceutical Joint Stock Company Announces the Resignation of Le Van Son as Chairman of the BOD	23-05-25	CI
OPC Pharmaceutical Joint Stock Company Announces the Remaining Cash Dividend in 2023, Payable on May 25, 2023	23-05-08	CI
Opc Pharmaceutical Joint Stock Company Announces Executive Changes	23-05-05	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
OPC Pharmaceutical Joint Stock Company Approves to Pay the First Cash Dividend for 2022, Payment Date: April 26, 2023	23-03-30	CI
OPC Pharmaceutical Joint Stock Company Announces Management Resignations	23-03-20	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-27	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-27	CI
OPC Pharmaceutical Joint Stock Company Appoints Phuong Thanh Nhung as Deputy Chairman of the Board of Director	22-12-22	CI
OPC Pharmaceutical Joint Stock Company Appoints Duong Minh Hung as Deputy CEO	22-11-17	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-28	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-24	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-01-27	CI
OPC Pharmaceutical Joint Stock Company Announces Establishment of the Audit Committee and Risk Management	21-12-09	CI
Opc Pharmaceutical Joint Stock Company Approves First Cash Dividend for 2021, Payable on March 15, 2022	21-12-08	CI
OPC Pharmaceutical Joint Stock Company Elect Members of the Board of Directors and Members of the Board of Supervisors	21-10-26	CI

Chart OPC Pharmaceutical

Duration

Period

More charts

Company Profile

OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
OPC PHARMACEUTICAL	+1.88%	61.56M
ELI LILLY AND COMPANY	+48.53%	780B
NOVO NORDISK A/S	+41.78%	627B
JOHNSON & JOHNSON	-6.37%	353B
MERCK & CO., INC.	+20.93%	334B
ABBVIE INC.	+8.21%	296B
ASTRAZENECA PLC	+17.94%	244B
ROCHE HOLDING AG	-1.02%	217B
NOVARTIS AG	+11.46%	214B
AMGEN INC.	+4.40%	161B